Experience, Expertise, Excellence: Dr Laliotis experience showcases a decade-long journey encompassing clinical care, research, and management in the medical domain. With ECFMG certification and six years of training in the USA, Dr. Laliotis brings profound insights into internal medicine and hematology/oncology. Specializing in biomarker utilization, biostatistics, and computational analysis, Dr. Laliotis excels in clinical trial operations and regulatory protocols, particularly in oncology therapeutics. A proven leader with a knack for communication and academic editing, Dr. Laliotis is a testament to skill and accomplishment in the medical landscape.

Read more articles on AI & Current Healthcare Matters in our platform in Docus.ai, an AI-Powered Health Platform

ARTICLES IN HEALTHCARE & AI

FEATURED NEWS & PRESS RELEASES

Global Healthcare Magazine — Dr. George Laliotis: The Architect of the Digital Twin and the End of Guesswork in Oncology

ReachMD — Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures

OncoDaily — George Laliotis: Peri-operative FOLFIRINOX improved outcomes in patients with pancreatic cancer

OncoDaily — New Paper Alert! Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial

Influent, The unScripted Podcast — Navigating Medical Training to Biotech with Dr. George Laliotis

PRLog — George Laliotis Earns Master of Public Health Degree from University of Nicosia

PRLog — George Laliotis Leads Breakthrough in Predicting Immunotherapy Effectiveness

PRLog — George Laliotis Completes Prestigious Clinical Research Program at Harvard Medical School

Research Outreach — Simple blood tests could predict immunotherapy effectiveness